Haig Bozigian

1.5k total citations
40 papers, 1.1k citations indexed

About

Haig Bozigian is a scholar working on Molecular Biology, Reproductive Medicine and Pharmacology. According to data from OpenAlex, Haig Bozigian has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Reproductive Medicine and 9 papers in Pharmacology. Recurrent topics in Haig Bozigian's work include Hypothalamic control of reproductive hormones (7 papers), Estrogen and related hormone effects (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Haig Bozigian is often cited by papers focused on Hypothalamic control of reproductive hormones (7 papers), Estrogen and related hormone effects (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). Haig Bozigian collaborates with scholars based in United States. Haig Bozigian's co-authors include Takung Chen, Dimitri E. Grigoriadis, R. Scott Struthers, Ajay Madan, Chen Chen, John Saunders, Yunfei Zhu, Roland Jimenez, Marc H. Davies and B. Alex Merrick and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Endocrinology.

In The Last Decade

Haig Bozigian

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haig Bozigian United States 23 240 213 190 125 121 40 1.1k
B. V. Rama Sastry United States 23 127 0.5× 727 3.4× 156 0.8× 239 1.9× 117 1.0× 112 1.9k
Michael L. Selley Australia 20 75 0.3× 437 2.1× 107 0.6× 12 0.1× 24 0.2× 26 1.8k
María Pilar Carrera-González Spain 17 47 0.2× 335 1.6× 113 0.6× 19 0.2× 19 0.2× 71 1.4k
Jie Shan Canada 15 25 0.1× 292 1.4× 159 0.8× 27 0.2× 207 1.7× 35 965
Stephen A. Ballard United Kingdom 15 48 0.2× 493 2.3× 119 0.6× 28 0.2× 79 0.7× 26 1.4k
Timothy J. Kowalski United States 24 109 0.5× 556 2.6× 145 0.8× 14 0.1× 36 0.3× 54 2.1k
Hiroshi Shinyama Japan 12 25 0.1× 402 1.9× 65 0.3× 35 0.3× 204 1.7× 38 2.3k
Yifan Chen United States 24 39 0.2× 577 2.7× 76 0.4× 15 0.1× 16 0.1× 61 1.8k
Ethan Hoffmann United States 22 23 0.1× 599 2.8× 124 0.7× 24 0.2× 48 0.4× 33 2.1k

Countries citing papers authored by Haig Bozigian

Since Specialization
Citations

This map shows the geographic impact of Haig Bozigian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haig Bozigian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haig Bozigian more than expected).

Fields of papers citing papers by Haig Bozigian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haig Bozigian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haig Bozigian. The network helps show where Haig Bozigian may publish in the future.

Co-authorship network of co-authors of Haig Bozigian

This figure shows the co-authorship network connecting the top 25 collaborators of Haig Bozigian. A scholar is included among the top collaborators of Haig Bozigian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haig Bozigian. Haig Bozigian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Smith, Evan, et al.. (2020). Effect of Paroxetine on the Pharmacokinetics of Valbenazine and its Active Metabolite (9). Neurology. 94(15_supplement). 1 indexed citations
3.
Williams, John P., et al.. (2018). VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine). Progress in medicinal chemistry. 57(1). 87–111. 26 indexed citations
4.
Jimenez, Roland, et al.. (2018). Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group. American Journal of Geriatric Psychiatry. 26(3). S159–S159. 1 indexed citations
5.
Skor, Heather, Evan B. Smith, Gordon Loewen, et al.. (2017). Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine. Drugs in R&D. 17(3). 449–459. 26 indexed citations
6.
Grigoriadis, Dimitri E., Evan Smith, Sam R.J. Hoare, Ajay Madan, & Haig Bozigian. (2017). Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites. Journal of Pharmacology and Experimental Therapeutics. 361(3). 454–461. 75 indexed citations
7.
Grigoriadis, Dimitri E., et al.. (2017). Pharmacologic Characteristics of Valbenazine (NBI-98854) and its Metabolites (P2.025). Neurology. 88(16_supplement). 1 indexed citations
8.
Madan, Ajay, Zhihong O’Brien, Chris O’Brien, et al.. (2009). A pharmacokinetic evaluation of five H1 antagonists after an oral and intravenous microdose to human subjects. British Journal of Clinical Pharmacology. 67(3). 288–298. 40 indexed citations
9.
Chen, Chen, Fábio C. Tucci, Wanlong Jiang, et al.. (2008). Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists. Bioorganic & Medicinal Chemistry. 16(10). 5606–5618. 18 indexed citations
10.
Chen, Chen, Yongsheng Chen, Joseph Pontillo, et al.. (2008). Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 18(11). 3301–3305. 13 indexed citations
11.
Madan, Ajay, Andrew J. Fisher, Liping Jin, Dennis E. Chapman, & Haig Bozigian. (2007). In vitrometabolism of indiplon and an assessment of its drug interaction potential. Xenobiotica. 37(7). 736–752. 18 indexed citations
12.
Struthers, R. Scott, Susan K. Sullivan, Greg J. Reinhart, et al.. (2006). Pharmacological Characterization of a Novel Nonpeptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor, NBI-42902. Endocrinology. 148(2). 857–867. 29 indexed citations
13.
14.
Foster, Alan C., Mary Ann Pelleymounter, Mary Jane Cullen, et al.. (2004). In Vivo Pharmacological Characterization of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic. Journal of Pharmacology and Experimental Therapeutics. 311(2). 547–559. 44 indexed citations
15.
Bozigian, Haig, et al.. (1994). Ondansetron Absorption in Adults: Effect of Dosage Form, Food, and Antacids. Journal of Pharmaceutical Sciences. 83(7). 1011–1013. 25 indexed citations
16.
Thurman, Ronald G., Wenshi Gao, Henry D. Connor, et al.. (1994). SPC-100270, a protein kinase C inhibitor, reduced hypoxic injury due to reperfusion following orthotopic liver transplantation in the rat. Transplant International. 7(s1). 167–170. 2 indexed citations
17.
Hsyu, Poe‐Hirr, J. Frederick Pritchard, Haig Bozigian, et al.. (1994). Comparison of the Pharmacokinetics of an Ondansetron Solution (8 mg) When Administered Intravenously, Orally, to the Colon, and to the Rectum. Pharmaceutical Research. 11(1). 156–159. 29 indexed citations
18.
Khor, S P, Haig Bozigian, & Michael Mayersohn. (1991). Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. II. Distribution of phencyclidine in the rat.. Drug Metabolism and Disposition. 19(2). 486–490. 48 indexed citations
19.
Eigenberg, David A., Haig Bozigian, Dean E. Carter, & I.G. Sipes. (1986). Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat. Journal of Toxicology and Environmental Health. 17(4). 445–456. 59 indexed citations
20.
Bozigian, Haig, et al.. (1984). Factors Influencing Circadian Rhythms in Acetaminophen Lethality. Pharmacology. 29(3). 149–157. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. V. Rama Sastry Breakdown of academic impact, for papers by Michael L. Selley Breakdown of academic impact, for papers by María Pilar Carrera-González Breakdown of academic impact, for papers by Jie Shan Breakdown of academic impact, for papers by Stephen A. Ballard Breakdown of academic impact, for papers by Timothy J. Kowalski Breakdown of academic impact, for papers by Hiroshi Shinyama Breakdown of academic impact, for papers by Yifan Chen Breakdown of academic impact, for papers by Ethan Hoffmann
Rankless by CCL
2026